title: Efficacy of 5-azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma.
authors.affiliation: Service d'hématologie adulte, Institut Imagine, Université Paris Descartes, Hôpital Necker, Assistance Publique-Hôpitaux de Paris, Paris, France.
authors.forename: Morgane
authors.initials: M
authors.lastname: Cheminant
authors.forename: Julie
authors.initials: J
authors.lastname: Bruneau
authors.forename: Olivier
authors.initials: O
authors.lastname: Kosmider
authors.forename: François
authors.initials: F
authors.lastname: Lefrere
authors.forename: Richard
authors.initials: R
authors.lastname: Delarue
authors.forename: Philippe
authors.initials: P
authors.lastname: Gaulard
authors.forename: Isabelle
authors.initials: I
authors.lastname: Radford
authors.forename: Coralie
authors.initials: C
authors.lastname: Derrieux
authors.forename: Olivier
authors.initials: O
authors.lastname: Hermine
authors.forename: François
authors.initials: F
authors.lastname: Lemonnier
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use*; D004252:DNA Mutational Analysis / Q000379:methods; D004273:DNA, Neoplasm / Q000235:genetics; D004268:DNA-Binding Proteins / Q000235:genetics*; D049308:Dioxygenases; D005260:Female; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000188:drug therapy*; D015477:Leukemia, Myelomonocytic, Chronic / Q000150:complications; D016411:Lymphoma, T-Cell, Peripheral / Q000188:drug therapy*; D009154:Mutation; D011518:Proto-Oncogene Proteins / Q000235:genetics*
chemical_list: D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D004268:DNA-Binding Proteins; D011518:Proto-Oncogene Proteins; D049308:Dioxygenases; C541081:TET2 protein, human; D001374:Azacitidine
keywords: 5-azacytidine; TET2 mutation; angioimmunoblastic T cell lymphoma; epigenetic